Literature DB >> 15280136

The international infections in pregnancy study: group B streptococcal colonization in pregnant women.

C G Whitney1, S Daly, S Limpongsanurak, M R Festin, K K Thinn, T Chipato, P Lumbiganon, J Sauvarin, W Andrews, J E Tolosa.   

Abstract

BACKGROUND: Heavy colonization with group B streptococcus (GBS) has been associated with increased risk of preterm birth and neonatal sepsis; the burden of neonatal GBS disease varies geographically. To determine whether variation in heavy colonization and GBS serotypes could contribute to geographic differences in disease burden, we assessed the prevalence of heavy colonization and the distribution of serotypes in asymptomatic pregnant women in multiple countries.
METHODS: Cervical, lower vaginal and urine samples were collected from women attending seven prenatal clinics in six countries. Light colonization was defined as GBS isolation from Lim broth only; heavy colonization was isolation from urine or sheep blood agar plates. Isolates were serotyped using capillary precipitation.
RESULTS: GBS was present in 11.3% of 1308 participants (range 7.1-21.7%); 5.0% were heavily colonized (0.4-18.8%) and 6.4% were lightly colonized (2.9-8.0%). Serotypes III and V were most common (both 17.2%). Serotypes VII and VIII were found in one study center.
CONCLUSIONS: The prevalence of heavy colonization and GBS serotypes varied significantly among our study centers. Whether this variation could in part explain geographic differences in neonatal morbidity and mortality is a hypothesis that needs further study.

Entities:  

Mesh:

Year:  2004        PMID: 15280136     DOI: 10.1080/14767050410001668617

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  16 in total

1.  Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract.

Authors:  Tamsin R Sheen; Alyssa Jimenez; Nai-Yu Wang; Anirban Banerjee; Nina M van Sorge; Kelly S Doran
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  Vaginal co-colonization with multiple Group B Streptococcus serotypes.

Authors:  Ameneh Khatami; Tara M Randis; Larissa Tavares; Margaret Gegick; Evan Suzman; Adam J Ratner
Journal:  Vaccine       Date:  2018-12-08       Impact factor: 3.641

3.  Probiotic interventions to reduce antepartum Group B streptococcus colonization: A systematic review and meta-analysis.

Authors:  Lisa Hanson; Leona VandeVusse; Emily Malloy; Mauricio Garnier-Villarreal; Lauren Watson; Alissa Fial; Marie Forgie; Katrina Nardini; Nasia Safdar
Journal:  Midwifery       Date:  2021-11-25       Impact factor: 2.640

4.  Diversity of group B streptococcus serotypes causing urinary tract infection in adults.

Authors:  Kimberly B Ulett; William H Benjamin; Fenglin Zhuo; Meng Xiao; Fanrong Kong; Gwendolyn L Gilbert; Mark A Schembri; Glen C Ulett
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

5.  Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization.

Authors:  Nai-Yu Wang; Kathryn A Patras; Ho Seong Seo; Courtney K Cavaco; Berenice Rösler; Melody N Neely; Paul M Sullam; Kelly S Doran
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

6.  Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines.

Authors:  Christopher J Gill; Jose B V Mantaring; William B Macleod; Myrna Mendoza; Sookee Mendoza; W Charles Huskins; Donald A Goldmann; Davidson H Hamer
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.

Authors:  Deepak S Ipe; Nouri L Ben Zakour; Matthew J Sullivan; Scott A Beatson; Kimberly B Ulett; William H Benjamin; Mark R Davies; Samantha J Dando; Nathan P King; Allan W Cripps; Mark A Schembri; Gordon Dougan; Glen C Ulett
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

Review 8.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

9.  Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.

Authors:  Donna A Santillan; Karishma K Rai; Mark K Santillan; Yogita Krishnamachari; Aliasger K Salem; Stephen K Hunter
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 10.693

10.  Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution.

Authors:  Danielle L Ippolito; Wesley A James; Deborah Tinnemore; Raywin R Huang; Mary J Dehart; Julie Williams; Mark A Wingerd; Samandra T Demons
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.